New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


The Analyst’s Take: Vision supplements poised for growth

Claire Morton
With emerging research on the effects of too much screen time, innovation in vision supplements increases growth projections. This is the latest installment of our twice-monthly data discussion from Nutrition Business Journal’s senior analyst.

Americans now spend over 11 hours a day with their eyes glued to a screen, according to Nielsen research. The effects of that blue light exposure on our eye health has been a recent subject of research across the supplements industry.

Due to this renewed focus, previously stagnant vision and eye health supplements are projected to spike in growth through 2019, reaching $554 million annually. Specific ingredients on the rise include lutein, lycopene, astaxanthin, zeaxanthin and meso-zeaxanthin.

See what products are growing in 22 categories, with 109 charts that show sales and growth by condition in the 2017 NBJ Condition Specific Report.

TAGS: General
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.